FMEDvsIBRN
Fidelity Covington Trust - Disruptive Medicine ETF against iShares Neuroscience and Healthcare ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| FMED | IBRN | |
|---|---|---|
| Expense ratio | 0.50% | 0.47% |
| Assets | $55M | $7864.21T |
| Net flow, 1 month | — | +$2M |
| Net flow, 1 year | — | +$2M |
| Return, YTD | +21.0% | +24.7% |
| Return, 1 year | +31.5% | +57.5% |
| Avg daily volume | 5K | 3K |
| Holdings | 63 | 54 |
| Listed | Jun 11, 2023 | Aug 23, 2022 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS